Doxorubicin: The dogma and the bone

QR Code

Doxorubicin: The dogma and the bone

Bibliographic Details
Main Authors:	Wong, J., Sriamornsak, P., Dass, Crispin
Format:	Journal Article
Published:	2016
Online Access:	http://hdl.handle.net/20.500.11937/28079

Similar Items

Stability of freeze-dried pH-responsive dextrin nanogels containing doxorubicin
by: Manchun, S., et al.
Published: (2016)

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
by: Tacar, O., et al.
Published: (2013)

Thiolated pectin–doxorubicin conjugates: Synthesis, characterization and anticancer activity studies
by: Cheewatanakornkool, K., et al.
Published: (2017)

Enhanced anti-tumor effect of pH-responsive dextrin nanogels delivering doxorubicin on colorectal cancer
by: Manchun, S., et al.
Published: (2015)

Redox-responsive microbeads containing thiolated pectin-doxorubicin conjugate inhibit tumor growth and metastasis: An in vitro and in vivo study
by: Cheewatanakornkool, K., et al.
Published: (2018)

Novel pH-responsive dextrin nanogels for doxorubicin delivery to cancer cells with reduced cytotoxicity to cardiomyocytes and stem cells
by: Manchun, S., et al.
Published: (2014)

Characterization and in vitro release studies of oral microbeads containing thiolated pectin-doxorubicin conjugates for colorectal cancer treatment
by: Cheewatanakornkool, K., et al.
Published: (2017)

Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015)

Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
by: Friedhuber, A., et al.
Published: (2015)

Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin
by: Tan, M., et al.
Published: (2010)

Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use
by: Baxter-Holland, M., et al.
Published: (2018)

Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013)

Biodegradable drug delivery systems for cancer therapy
by: Wong, T., et al.
Published: (2017)

Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013)

'The dogma is the drama': participation and sacramentality in the plays of Dorothy L. Sayers
by: Wiedemann Hunt, Margaret
Published: (2017)

'Merdekakan' sektor pertanian daripada dogma lama,dasar usang
by: Mohamed Arshad, Fatimah
Published: (2023)

Bone drug targets
by: Dass, Crispin
Published: (2018)

Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
by: Tacar, O., et al.
Published: (2015)

Designing nanoemulsion templates for fabrication of dextrin nanoparticles via emulsion cross-linking technique
by: Manchun, S., et al.
Published: (2014)

Targeted therapy for cancer using pH-responsive nanocarrier systems
by: Manchun, S., et al.
Published: (2012)

In vitro delivery and controlled release of doxorubicin for targeting osteosarcoma bone cancer
by: Kamba, Shafiu Abdullahi, et al.
Published: (2013)

Bone morphogenetic protein-2 and bone therapy: Successes and pitfalls
by: Poon, B., et al.
Published: (2016)

Potential of pigment epithelium-derived factor (PEDF) as a bone regenerative biopharmaceutical
by: Lee, P., et al.
Published: (2016)

Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy
by: Baxter-Holland, M., et al.
Published: (2018)

Weak bones in diabetes mellitus - an update on pharmaceutical treatment options
by: Lin, D., et al.
Published: (2017)

Treatment of bone disorders with parathyroid hormone: Success and pitfalls
by: Ng, P., et al.
Published: (2016)

Stimulation of bone regeneration with pigment epithelium-derived factor microparticles: Evidence in silico, in vitro and in vivo
by: Lee, P., et al.
Published: (2016)

Prolonged duration of antibiotic therapy to reduce recurrent urinary tract infections in an aged residential care population: Is it time for a change in dogma?
by: Wee, J., et al.
Published: (2007)

Transdifferentiation of myoblasts into osteoblasts - possible use for bone therapy
by: Lin, Daphne, et al.
Published: (2017)

The potential role of free chitosan in bone trauma and bone cancer management
by: Tan, M., et al.
Published: (2014)

Breast cancer bone metastases: pathogenesis and therapeutic targets
by: Brook, Naomi, et al.
Published: (2018)

Systemic leptin administration alters callus VEGF levels and enhances bone fracture healing in wildtype and ob/ob mice
by: Wu, Z., et al.
Published: (2018)

Alginate bead-encapsulated PEDF induces ectopic bone formation in vivo in the absence of co-administered mesenchymal stem cells.
by: Elahy, M., et al.
Published: (2015)

Influence of polymer size on uptake and cytotoxicity of doxorubicin-loaded DNA–PEG conjugates
by: Purdie, Laura, et al.
Published: (2016)

Alkyl-modified oligonucleotides as intercalating vehicles for doxorubicin uptake via albumin binding
by: Purdie, Laura, et al.
Published: (2018)

Morphological Changes in the Liver of Rats (Rattus norvegicus) treated with different Doses of Doxorubicin
by: Al-Saleem, Ilham A., et al.
Published: (2017)

Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone
by: Alcantara, M., et al.
Published: (2014)

Using transcriptomics to inform the next generation risk assessment of doxorubicin and niacinamide
by: Tulum, Elizabeth Ann
Published: (2024)

Drug delivery in cancer using liposomes
by: Dass, Crispin
Published: (2008)

Ascochlorin enhances the sensitivity of doxorubicin leading to the reversal of epithelial-to-mesenchymal transition in hepatocellular carcinoma
by: Dai, X., et al.
Published: (2016)